The George Washington University Cancer Center

What The George Washington University Cancer Center does

The George Washington University Cancer Center is a non-profit academic cancer center founded in 2015 and operated as an integrated division of the George Washington University School of Medicine and Health Sciences. It delivers multidisciplinary cancer care — including treatment for common cancers (breast, lung, prostate, colorectal) and complex/rare conditions — alongside a clinical trials program, specialized clinical programs, and research initiatives focused on advancing cancer care and informing health-systems policy. Patients access the center through physician referrals, the GWdocs.com appointment portal, and GW MFA's network, with inpatient and surgical services provided via an embedded relationship with GW Hospital. Revenue is generated through three primary streams: patient care services (billed to insurance and patients), federal and private research grants, and medical education and training programs; specific pricing is not publicly disclosed. The center also runs community outreach, prevention, early detection, survivorship, and patient/caregiver support programs targeting the Washington, D.C. region, with stated intent to influence cancer policy and reduce regional cancer burden.

The center is structurally small (42 listed employees) but leverages its parent university's academic resources, research infrastructure, and brand recognition. Its competitive position rests on GW-affiliated talent, the GW Hospital / GW MFA / GW SMHS ecosystem, and access to clinical trials. The most recent publicly noted strategic event is the June 2026 retirement of Elmer E. Huerta, MD, MPH, after nearly 50 years of service as a cancer-prevention leader, which represents a significant continuity transition for the organization.

Name

The George Washington University Cancer Center

Legal name

The George Washington University Cancer Center

Website

https://gwcancercenter.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The George Washington University Cancer Center is a non-profit academic cancer center within GW's School of Medicine and Health Sciences that provides multidisciplinary cancer treatment, clinical trials, research, and community outreach to patients across the Washington, D.C. region.

Ownership category

akta.pro rank

Product category

Academic Cancer Center Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Investigator & Site Training / GCP Support (HLAGACAF)

Keywords

• Cancer treatment services
• Clinical trials oncology
• Cancer research programs
• Cancer prevention outreach
• Medical education training

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Patient Care Services: Revenue generated through patient care services billed to insurance providers and patients directly. As an academic medical center, services include treatment, clinical trials participation, and specialized cancer care.
2. Research Grants and Funding: Federal and private research grants funding cancer research programs, clinical trials, and scientific investigation conducted at the center.
3. Educational Programs: Medical education and training programs for healthcare professionals, contributing to institutional funding.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

The GW Cancer Center is an academic medical center that delivers multidisciplinary cancer treatment for common and rare cancers, administers clinical trials and innovative therapies, runs specialized clinical programs, conducts cancer research, and provides patient, family, and caregiver support including survivorship resources. It operates as part of The George Washington University School of Medicine and Health Sciences in partnership with GW Hospital and GW MFA to coordinate care across prevention, treatment, and survivorship.

Product overview

The GW Cancer Center is a single integrated cancer care center offering coordinated services across multiple domains: cancer treatment for various cancer types (breast, lung, prostate, colorectal, and rare conditions), a clinical trials program providing access to innovative therapies, clinical programs for specialized care, comprehensive research initiatives, community outreach and engagement for prevention and early detection, and patient/caregiver support services including survivorship and screening resources. These offerings work together to deliver multidisciplinary, forward-looking cancer care focused on improving patient outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

• Cancer Treatment Services Multidisciplinary cancer care covering common cancers (breast, lung, prostate, colorectal) and complex or rare conditions, delivered by specialists providing advanced treatment and compassionate support.
• Clinical Trials Program Access to innovative therapies and clinical trials designed to improve patient outcomes and shape the future of cancer care, delivered through GWdocs.com.
• Clinical Programs Specialized clinical programs offering coordinated, forward-looking cancer care across multiple disciplines.
• Cancer Research Comprehensive research initiatives focused on advancing cancer care and influencing health systems policy to reduce the cancer burden.
• Community Outreach and Engagement Prevention, early detection, and community partnership programs designed to reduce cancer burden in the region.
• Patient and Caregiver Support Supporting services for patients, families, and caregivers including survivorship programs, prevention and screening resources, and prepared patient materials.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• GW SMHS (School of Medicine and Health Sciences)coreStrategic or Co-development PartnerGW Cancer Center operates as an integral part of The George Washington University School of Medicine and Health Sciences, leveraging academic resources, research capabilities, and educational programs for comprehensive cancer care.
• GW MFA (Medical Faculty Associates)coreStrategic or Co-development PartnerPartnership with GW MFA provides physician directory and appointment scheduling services, serving as the primary referral and patient intake channel for the GW Cancer Center.
• GW HospitalcoreStrategic or Co-development PartnerCollaboration with GW Hospital provides inpatient facilities and comprehensive hospital services for cancer patients requiring hospitalization or surgical procedures.

Recent moves4 records

Expansion highlights4 records

Direct peers

• Georgetown Lombardi Comprehensive Cancer Center: Georgetown Lombardi is the other NCI-designated academic cancer center in Washington, DC, offering multidisciplinary cancer treatment, clinical trials, and research within a university medical setting, making it the closest direct peer to GW Cancer Center in both geography and mission.
• Johns Hopkins Sidney Kimmel Comprehensive Cancer Center: Johns Hopkins Sidney Kimmel is an NCI-designated comprehensive cancer center in the Mid-Atlantic region delivering multidisciplinary cancer care, clinical trials, and translational research within an academic medical center, structurally analogous to GW Cancer Center but at greater scale.
• University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center: Greenebaum Cancer Center is a Baltimore-based NCI-designated academic cancer center that provides multidisciplinary cancer treatment, clinical trials, and research within the University of Maryland Medical System, competing with GW for Mid-Atlantic oncology patients and research funding.
• MedStar Georgetown University Hospital Cancer Institute: MedStar Georgetown operates hospital-integrated cancer services within the same DC market as GW Cancer Center, offering clinical programs, clinical trials access, and multidisciplinary care closely comparable in scope and target population.

Broad incumbents

• University of Virginia Cancer Center: UVA Cancer Center is a Mid-Atlantic NCI-designated academic cancer center offering multidisciplinary treatment, clinical trials, and research within the UVA Health System, similar in structure and regional positioning to GW Cancer Center.
• Vanderbilt-Ingram Cancer Center: Vanderbilt-Ingram is an NCI-designated comprehensive cancer center at a major research university, providing multidisciplinary treatment, clinical trials, and translational research comparable in academic structure and mission to GW Cancer Center.
• MD Anderson Cancer Center: MD Anderson is the largest NCI-designated comprehensive cancer center in the U.S., delivering the full spectrum of cancer treatment, clinical trials, and research that defines the gold-standard academic cancer center model GW Cancer Center operates within.
• Duke Cancer Institute: Duke Cancer Institute is an NCI-designated comprehensive cancer center at a large private research university, offering academic oncology care, clinical trials, and translational research comparable to GW Cancer Center's offerings but with significantly greater scale.
• Yale Cancer Center: Yale Cancer Center is an NCI-designated comprehensive cancer center delivering multidisciplinary oncology treatment, clinical trials, and translational research across the Northeast, providing a comparable academic-medical-center operating model to GW Cancer Center at greater scale.

Others

• National Cancer Institute (NCI): The NCI is the federal agency that designates and oversees academic cancer centers, providing research grants, clinical trial infrastructure, and policy frameworks that GW Cancer Center relies on for funding, scientific standards, and programmatic direction.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/gw-cancer-center

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The George Washington University Cancer Center